These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29167034)

  • 1. Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: Results from a pilot randomized controlled trial.
    Ghielen I; van Wegen EEH; Rutten S; de Goede CJT; Houniet-de Gier M; Collette EH; Burgers-Bots IAL; Twisk JWR; Kwakkel G; Vermunt K; van Vliet B; Berendse HW; van den Heuvel OA
    J Psychosom Res; 2017 Dec; 103():1-8. PubMed ID: 29167034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BEWARE: Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: study protocol for a randomized controlled trial.
    Ghielen I; van den Heuvel OA; de Goede CJ; Houniet-de Gier M; Collette EH; Burgers-Bots IA; Rutten S; Kwakkel G; Vermunt K; van Vliet B; Berendse HW; van Wegen EE
    Trials; 2015 Jun; 16():283. PubMed ID: 26101038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of yoga versus stretching and resistance training exercises on psychological distress for people with mild-to-moderate Parkinson's disease: study prxotocol for a randomized controlled trial.
    Kwok JYY; Kwan JCY; Auyeung M; Mok VCT; Chan HYL
    Trials; 2017 Nov; 18(1):509. PubMed ID: 29096672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A wearable proprioceptive stabilizer (Equistasi®) for rehabilitation of postural instability in Parkinson's disease: a phase II randomized double-blind, double-dummy, controlled study.
    Volpe D; Giantin MG; Fasano A
    PLoS One; 2014; 9(11):e112065. PubMed ID: 25401967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation.
    Pacchetti C; Mancini F; Aglieri R; Fundarò C; Martignoni E; Nappi G
    Psychosom Med; 2000; 62(3):386-93. PubMed ID: 10845352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-centered integrated healthcare improves quality of life in Parkinson's disease patients: a randomized controlled trial.
    Eggers C; Dano R; Schill J; Fink GR; Hellmich M; Timmermann L;
    J Neurol; 2018 Apr; 265(4):764-773. PubMed ID: 29392459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled expressive writing pilot in individuals with Parkinson's disease and their caregivers.
    Cash TV; Lageman SK
    BMC Psychol; 2015 Nov; 3():44. PubMed ID: 26621025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and coping as predictors of change after deep brain stimulation in Parkinson's disease.
    Soulas T; Sultan S; Gurruchaga JM; Palfi S; Fénelon G
    World Neurosurg; 2011; 75(3-4):525-32. PubMed ID: 21600507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive behavioural therapy for anxiety disorders in Parkinson's disease: Design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivity.
    Mulders AEP; Moonen AJH; Dujardin K; Kuijf ML; Duits A; Flinois B; Handels RLH; Lopes R; Leentjens AFG
    J Psychosom Res; 2018 Sep; 112():32-39. PubMed ID: 30097133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial.
    Antonini A; Gentile G; Giglio M; Marcante A; Gage H; Touray MML; Fotiadis DI; Gatsios D; Konitsiotis S; Timotijevic L; Egan B; Hodgkins C; Biundo R; Pellicano C;
    Trials; 2018 Sep; 19(1):492. PubMed ID: 30217235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rasagiline for dysexecutive symptoms during wearing-off in Parkinson's disease: a pilot study.
    Rinaldi D; Assogna F; Sforza M; Tagliente S; Pontieri FE
    Neurol Sci; 2018 Jan; 39(1):141-143. PubMed ID: 28956175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goal-orientated cognitive rehabilitation for dementias associated with Parkinson's disease-A pilot randomised controlled trial.
    Hindle JV; Watermeyer TJ; Roberts J; Brand A; Hoare Z; Martyr A; Clare L
    Int J Geriatr Psychiatry; 2018 May; 33(5):718-728. PubMed ID: 29314218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Parkinson's Active Living (PAL) Program.
    Butterfield LC; Cimino CR; Salazar R; Sanchez-Ramos J; Bowers D; Okun MS
    J Geriatr Psychiatry Neurol; 2017 Jan; 30(1):11-25. PubMed ID: 28248557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT).
    van der Marck MA; Munneke M; Mulleners W; Hoogerwaard EM; Borm GF; Overeem S; Bloem BR;
    Lancet Neurol; 2013 Oct; 12(10):947-56. PubMed ID: 23988337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of brief interventions for managing depression and anxiety symptoms during early discharge period after stroke: a pilot randomized controlled trial.
    Hoffmann T; Ownsworth T; Eames S; Shum D
    Top Stroke Rehabil; 2015 Apr; 22(2):116-26. PubMed ID: 25936543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive rehabilitation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial.
    Hindle JV; Watermeyer TJ; Roberts J; Martyr A; Lloyd-Williams H; Brand A; Gutting P; Hoare Z; Edwards RT; Clare L
    Trials; 2016 Mar; 17():152. PubMed ID: 27000036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.